Loading organizations...
Loading organizations...
Bioscience Vaccines: Biotechnology company developing proprietary vaccine adjuvant technologies to enhance immune response for human and animal health.
Bioscience Vaccines is a West Lafayette, Indiana-based specialized biotechnology company that develops proprietary vaccine adjuvant technologies designed to enhance immune responses and reduce manufacturing costs. Operating with a small team of fewer than 10 employees, the startup utilizes early-stage seed funding, angel investments, and federal research grants to advance its biomaterial-based adjuvant platform. The enterprise focuses on licensing its technology to larger pharmaceutical manufacturers operating within both the human and animal health immunology sectors. The firm has historically collaborated with notable institutions like the Purdue Research Park and the Purdue University College of Veterinary Medicine to conduct testing partnerships and secure a United States patent in 2013. Bioscience Vaccines was founded in 2007 as a university spin-out by inventor Dr. Mark Suckow, who subsequently brought on Thomas Tillett to serve as chief executive officer.
Bioscience Vaccines has raised $550K across 2 funding rounds.
Bioscience Vaccines has raised $550K in total across 2 funding rounds.
Bioscience Vaccines has raised $550K in total across 2 funding rounds.
Bioscience Vaccines's investors include Joe Hornett, BioCrossroads.
Bioscience Vaccines has raised $550K across 2 funding rounds. Most recently, it raised $150K Other Equity in July 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 25, 2011 | $150K Other Equity | Joe Hornett | |
| Feb 19, 2010 | $400K Seed | BioCrossroads |